[Hemostasis in patients with systemic skin diseases].
Examinations of the hemostasis system parameters in patients with scleroderma, psoriatic arthritis, malignant lymphoma of the skin have revealed a significant elevation of fibrinogen concentration, acceleration of blood clotting time, increased prothrombin consumption in all the patients. Elevation of the prothrombin index was detected in the patients with scleroderma and psoriatic arthritis. A direct relationship between the disease severity, size of the involvement of the skin integument, inflammation activity in the joints, and severity of hemostasis impairment has been revealed.
Dovzhanskiĭ
S I
SI
Gerasimova
M V
MV
Rumiantseva
E V
EV
D000293:Adolescent; D000328:Adult; D015535:Arthritis, Psoriatic / Q000097:blood; D005260:Female; D006487:Hemostasis; D006801:Humans; D008223:Lymphoma / Q000097:blood; D008297:Male; D008875:Middle Aged; D012594:Scleroderma, Localized / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood; D012871:Skin Diseases / Q000097:blood*; D012878:Skin Neoplasms / Q000097:blood
Gemostaz u bol'nykh sistemnymi zabolevaniiami kozhi.